Jessica Pollard

5PUBLICATIONS
57CO-AUTHORS
Haematological tumoursInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|Aug 06, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia.

Lauren M Harmon, Zachary S Hattig, Yizhou Peter Huang

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

|Mar 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.

Jessica A Pollard, Todd A Alonzo, Robert Gerbing

|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.

Jessica A Pollard, Erin Guest, Todd A Alonzo

Pageof 1

Frequent Collaborators

3 joint publications

Mike R Loken

3 joint publications

Richard Aplenc

2 joint publications

Edward Anders Kolb

2 joint publications

Alan S Gamis